The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients
Introduction: Whether red blood cell (RBC) transfusion is beneficial remains controversial. In both retrospective and prospective evaluations, transfusion has been associated with adverse, neutral, or protective effects. These varying results likely stem from a complex interplay between transfusion...
Main Authors: | , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2014
|
Online Access: | http://hdl.handle.net/1721.1/90402 |
_version_ | 1826202923642650624 |
---|---|
author | Dejam, Andre Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra A Pinto, Duane S Samani, Zahra Malley, Brian E. Celi, Leo Anthony G. |
author2 | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
author_facet | Massachusetts Institute of Technology. Institute for Medical Engineering & Science Dejam, Andre Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra A Pinto, Duane S Samani, Zahra Malley, Brian E. Celi, Leo Anthony G. |
author_sort | Dejam, Andre |
collection | MIT |
description | Introduction:
Whether red blood cell (RBC) transfusion is beneficial remains controversial. In both retrospective and prospective evaluations, transfusion has been associated with adverse, neutral, or protective effects. These varying results likely stem from a complex interplay between transfusion, patient characteristics, and clinical context. The objective was to test whether age, comorbidities, and clinical context modulate the effect of transfusion on survival.
Methods:
By using the multiparameter intelligent monitoring in intensive care II database (v. 2.6), a retrospective analysis of 9,809 critically ill patients, we evaluated the effect of RBC transfusion on 30-day and 1-year mortality. Propensity score modeling and logistic regression adjusted for known confounding and assessed the independent effect of transfusion on 30-day and 1-year mortality. Sensitivity analysis was performed by using 3,164 transfused and non-transfused pairs, matched according the previously validated propensity model for RBC transfusion.
Results:
RBC transfusion did not affect 30-day or 1-year mortality in the overall cohort. Patients younger than 55 years had increased odds of mortality (OR, 1.71; P < 0.01) with transfusion. Patients older than 75 years had lower odds of 30-day and 1-year mortality (OR, 0.70; P < 0.01) with transfusion. Transfusion was associated with worse outcome among patients undergoing cardiac surgery (OR, 2.1; P < 0.01). The propensity-matched population corroborated findings identified by regression adjustment.
Conclusion:
A complex relation exists between RBC transfusion and clinical outcome. Our results show that transfusion is associated with improved outcomes in some cohorts and worse outcome in others, depending on comorbidities and patient characteristics. As such, future investigations and clinical decisions evaluating the value of transfusion should account for variations in baseline characteristics and clinical context. |
first_indexed | 2024-09-23T12:26:55Z |
format | Article |
id | mit-1721.1/90402 |
institution | Massachusetts Institute of Technology |
language | English |
last_indexed | 2024-09-23T12:26:55Z |
publishDate | 2014 |
publisher | BioMed Central Ltd |
record_format | dspace |
spelling | mit-1721.1/904022022-10-01T09:10:29Z The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients Dejam, Andre Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra A Pinto, Duane S Samani, Zahra Malley, Brian E. Celi, Leo Anthony G. Massachusetts Institute of Technology. Institute for Medical Engineering & Science Harvard University--MIT Division of Health Sciences and Technology Malley, Brian E. Feng, Mengling Cismondi, Federico Park, Shinhyuk Celi, Leo Anthony G. Introduction: Whether red blood cell (RBC) transfusion is beneficial remains controversial. In both retrospective and prospective evaluations, transfusion has been associated with adverse, neutral, or protective effects. These varying results likely stem from a complex interplay between transfusion, patient characteristics, and clinical context. The objective was to test whether age, comorbidities, and clinical context modulate the effect of transfusion on survival. Methods: By using the multiparameter intelligent monitoring in intensive care II database (v. 2.6), a retrospective analysis of 9,809 critically ill patients, we evaluated the effect of RBC transfusion on 30-day and 1-year mortality. Propensity score modeling and logistic regression adjusted for known confounding and assessed the independent effect of transfusion on 30-day and 1-year mortality. Sensitivity analysis was performed by using 3,164 transfused and non-transfused pairs, matched according the previously validated propensity model for RBC transfusion. Results: RBC transfusion did not affect 30-day or 1-year mortality in the overall cohort. Patients younger than 55 years had increased odds of mortality (OR, 1.71; P < 0.01) with transfusion. Patients older than 75 years had lower odds of 30-day and 1-year mortality (OR, 0.70; P < 0.01) with transfusion. Transfusion was associated with worse outcome among patients undergoing cardiac surgery (OR, 2.1; P < 0.01). The propensity-matched population corroborated findings identified by regression adjustment. Conclusion: A complex relation exists between RBC transfusion and clinical outcome. Our results show that transfusion is associated with improved outcomes in some cohorts and worse outcome in others, depending on comorbidities and patient characteristics. As such, future investigations and clinical decisions evaluating the value of transfusion should account for variations in baseline characteristics and clinical context. National Institute for Biomedical Imaging and Bioengineering (U.S.) (Grant R01 EB001659)) 2014-09-26T16:51:55Z 2014-09-26T16:51:55Z 2014-08 2013-12 2014-09-24T19:02:59Z Article http://purl.org/eprint/type/JournalArticle 1364-8535 1875-7081 http://hdl.handle.net/1721.1/90402 Dejam, Andre, Brian E Malley, Mengling Feng, Federico Cismondi, Shinhyuk Park, Saira Samani, Zahra Samani, Duane S Pinto, and Leo A Celi. “The Effect of Age and Clinical Circumstances on the Outcome of Red Blood Cell Transfusion in the Critically Ill Patients.” Crit Care 18, no. 4 (2014): 487. en http://dx.doi.org/10.1186/s13054-014-0487-z Critical Care Creative Commons Attribution http://creativecommons.org/licenses/by/4.0 Andre Dejam et al.; licensee BioMed Central Ltd. application/pdf BioMed Central Ltd BioMed Central Ltd |
spellingShingle | Dejam, Andre Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra A Pinto, Duane S Samani, Zahra Malley, Brian E. Celi, Leo Anthony G. The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients |
title | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients |
title_full | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients |
title_fullStr | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients |
title_full_unstemmed | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients |
title_short | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients |
title_sort | effect of age and clinical circumstances on the outcome of red blood cell transfusion in the critically ill patients |
url | http://hdl.handle.net/1721.1/90402 |
work_keys_str_mv | AT dejamandre theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT fengmengling theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT cismondifederico theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT parkshinhyuk theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT samanisaira theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT samanizahraa theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT pintoduanes theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT samanizahra theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT malleybriane theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT celileoanthonyg theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT dejamandre effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT fengmengling effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT cismondifederico effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT parkshinhyuk effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT samanisaira effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT samanizahraa effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT pintoduanes effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT samanizahra effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT malleybriane effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients AT celileoanthonyg effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusioninthecriticallyillpatients |